L. Marčák, J. Adam
Endometrial cancer is one of the most common neoplasms in gynaecological oncology
and the most common genital cancer in women in developed countries. It is generally
regarded as a malignant tumour with good prognosis. The mean age of diagnosis
of endometrial cancer is 60 years. The most common clinical symptom is postmenopausal
bleeding. Surgical treatment is the basic treatment modality for the treatment
of endometrial cancer. The role of lymphadenectomy in the surgical management of
endometrial cancer remains controversial. The value of lymphadenectomy in the management
of endometrial cancer is rapidly evolving. Lymphadenectomy remains the
gold standard for detecting metastatic disease to the regional nodes. In this review,
we discuss the controversies surrounding lymphadenectomy for endometrial cancer.